PMID: 6109767Feb 1, 1981Paper

Leukocyte sulfatidase for the reliable diagnosis of metachromatic leukodystrophy

Journal of Neurochemistry
S S RaghavanE H Kolodny

Abstract

A simple assay technique for the determination of sulfatidase activity in leukocytes has been developed for the reliable diagnosis of metachromatic leukodystrophy (MLD). Sulfatide is tritiated in sphingosine and fatty acid by reduction with [3H]sodium borohydride in alkali in the presence of palladium chloride. This labeled natural substrate for aryl sulfatase A (AsA) is hydrolyzed by normal human leukocytes in 25 mM-acetate buffer, pH 5.0, in the presence of 0.3% sodium taurodeoxycholate. The enzyme activity is greatly improved after dialysis, exhibiting better linearity with protein concentration. It is stimulated maximally by 5 mM-MnCl2 with an apparent Km of 0.17 mM for the substrate. Patients with MLD exhibited virtually no detectable sulfatidase activity although they had residual AsA activity that was measured with the synthetic substrate, p-nitrocatechol sulfate (NCS). Potential heterozygotes could be identified by the sulfatidase assay in instances where the NCS assay for AsA was inconclusive. Several individuals with levels of AsA activity characteristic of MLD, including a few healthy carriers and certain patients with unknown neurological diseases, were shown not to have MLD by the presence of measurable levels of s...Continue Reading

References

Nov 15, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·E Shapira, H L Nadler
Jul 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·E H Kolodny, R A Mumford
Sep 15, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Christomanou, K Sandhoff
Nov 1, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·A Poulos, K Beckman
Jul 2, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·A Poulos, K Beckman
Jul 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·T HaltiaJ Palo
Apr 28, 1978·Biochimica Et Biophysica Acta·G Schwarzmann
Oct 1, 1978·Clinical Genetics·J ButterworthA J Keay
Mar 12, 1970·The New England Journal of Medicine·H L Nadler, A B Gerbie
Nov 1, 1974·Lipids·A L FluhartyG Kritchevsky
Jun 28, 1973·The New England Journal of Medicine·J G LeroyC Navarro
Jan 1, 1972·Journal of Neurochemistry·A K PercyM M Kaback
Mar 8, 1972·Biochimica Et Biophysica Acta·M T PorterH Kihara
Aug 6, 1971·Biochemical and Biophysical Research Communications·M T PorterH Kihara
Sep 1, 1970·Clinica Chimica Acta; International Journal of Clinical Chemistry·N Taniguchi, I Nanba
Sep 30, 1971·The New England Journal of Medicine·A K Percy, M M Kaback
Mar 25, 1968·Biochimica Et Biophysica Acta·E Mehl, H Jatzkewitz
May 1, 1959·Clinica Chimica Acta; International Journal of Clinical Chemistry·H BAUMB SPENCER
Dec 1, 1963·Journal of Neurochemistry·J H AUSTINB K BACHHAWAT
May 3, 1965·Biochemical and Biophysical Research Communications·E MEHL, H JATZKEWITZ

❮ Previous
Next ❯

Citations

Apr 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·M Lee-Vaupel, E Conzelmann
Sep 15, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·M Lee-Vaupel, E Conzelmann
Jul 27, 2012·Journal of Child Neurology·David R LynchGihan Tennekoon
Mar 1, 1990·Molecular and Chemical Neuropathology·S N Shah
Jul 1, 1985·Journal of Neurochemistry·F B JungalwalaV S Sapirstein
Jan 1, 1981·American Journal of Medical Genetics·J ZlotogoraG Bach
Jan 1, 1983·American Journal of Medical Genetics·J Zlotogora, G Bach
Mar 1, 1987·American Journal of Medical Genetics·M HerskaG Bach
Aug 1, 1992·American Journal of Medical Genetics·Z G LiP L Chang
Jan 1, 1987·Acta Neurologica Scandinavica·I Reider-Grosswasser, N Bornstein
Apr 28, 1995·The Journal of Biological Chemistry·S K SundaramM Lev
Aug 1, 1988·Clinical Genetics·A H FensomR Sheridan
Aug 1, 1985·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·K FarrellA V Savage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.